A selective endothelin-receptor antagonist to reduce blood pressure in patients with treatment-resistant hypertension: a randomised, double-blind, placebo-controlled trial.
lancet-2009-a-selective-endothelin-eceptor-antagonist-to-reduce-blood-pressure-in-patients-with-treatment-resistant-hypertension-a-randomised-double-blind-placebo-controlled-trialPor: Michael A Weber, Henry Black, George Bakris, Henry Krum, Stuart Linas, Robert Weiss, Jennifer V Linseman, Brian L Wiens, Marshelle S Warren y Lars H Lindholm. www.thelancet.com Published online September 14, 2009.
Comentarios desactivados